Genetic and shared environmental risk factors do not lead to eosinophil activation in healthy twins of IBD patients

Abstract Objective To examine the role of eosinophils in the pre-diagnostic phase of inflammatory bowel disease (IBD), we studied the influence of genetic and shared environmental risk factors in a twin cohort of IBD. Material and methods We analysed eosinophil derived neurotoxin (EDN) and eosinophil cationic protein (ECP) in faecal samples from twin pairs with Crohn’s disease (n = 37) or ulcerative colitis (n = 21) and from external healthy controls (n = 44). Eosinophils stained with eosinophil peroxidase (EPO) were quantified in rectal biopsies. Ratios with 95% confidence intervals were calculated. Results Twins with Crohn’ disease displayed higher levels of EDN (Ratio = 2.98, 1.65–5.37) and ECP (Ratio 1.83, 1.24–2.70) than their healthy siblings. Levels did not differ between healthy twin-siblings and external controls (EDN, Ratio = 1.52, 0.79–2.94 and ECP, Ratio = 0.93, 0.56–1.54). Higher levels of EDN (Ratio = 2.43, 1.13–5.24) and ECP (Ratio = 1.53, 0.92–2.53) were observed among twins with ulcerative colitis vs their healthy siblings. Levels did not differ between healthy twin-siblings and external controls (EDN, Ratio = 1.08, 0.51–2.25 and ECP, Ratio = 1.29, 0.74–2.26). Using intra-class correlation coefficient (ICC), we found no agreement in levels of EDN or ECP in discordant pairs, except for ECP in monozygotic Crohn’s disease pairs (ICC = 0.63). In contrast, agreement was observed in monozygotic pairs concordant for Crohn’s disease (EDN, ICC = 0.67 and ECP, ICC = 0.66). The number of eosinophils in rectum was increased in twins with ulcerative colitis vs their healthy sibling (Ratio = 2.22, 1.50–3.27). Conclusions Activation of eosinophils in IBD seems to be a consequence of inflammation rather than an effect of genetic and shared environmental risk factors alone.

[1]  V. Apostolopoulos,et al.  Eosinophils in Inflammatory Bowel Disease. , 2019, Inflammatory bowel diseases.

[2]  S. Mathur,et al.  Comparison of IL-33 and IL-5 family mediated activation of human eosinophils , 2019, bioRxiv.

[3]  K. Papadakis,et al.  Mechanisms of Disease: Inflammatory Bowel Diseases. , 2019, Mayo Clinic proceedings.

[4]  C. Lindqvist,et al.  Gut Barrier Dysfunction—A Primary Defect in Twins with Crohn’s Disease Predominantly Caused by Genetic Predisposition , 2018, Journal of Crohn's & colitis.

[5]  P. Rutgeerts,et al.  Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease. , 2016, Journal of Crohn's & colitis.

[6]  M. Dubinsky,et al.  Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities , 2016, Gut.

[7]  Y. Kinoshita,et al.  The Number and Distribution of Eosinophils in the Adult Human Gastrointestinal Tract: A Study and Comparison of Racial and Environmental Factors , 2015, The American journal of surgical pathology.

[8]  Paige Lacy,et al.  Eosinophil Cytokines, Chemokines, and Growth Factors: Emerging Roles in Immunity , 2014, Front. Immunol..

[9]  L. Bodin,et al.  Subclinical Inflammation with Increased Neutrophil Activity in Healthy Twin Siblings Reflect Environmental Influence in the Pathogenesis of Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[10]  M. Johannesson,et al.  The Swedish Twin Registry: Establishment of a Biobank and Other Recent Developments , 2012, Twin Research and Human Genetics.

[11]  B. Monsarrat,et al.  IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G , 2012, Proceedings of the National Academy of Sciences.

[12]  J. Söderholm,et al.  Importance of disrupted intestinal barrier in inflammatory bowel diseases , 2011, Inflammatory bowel diseases.

[13]  Anders F. Andersson,et al.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.

[14]  P. Venge The eosinophil and airway remodelling in asthma , 2010, The clinical respiratory journal.

[15]  J. Ludvigsson,et al.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research , 2009, European Journal of Epidemiology.

[16]  Janet K. Jansson,et al.  Twin studies reveal specific imbalances in the mucosa‐associated microbiota of patients with ileal Crohn's disease , 2009, Inflammatory bowel diseases.

[17]  M. Rothenberg,et al.  Biology of the eosinophil. , 2009, Advances in immunology.

[18]  O. Winqvist,et al.  Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis , 2008, Journal of leukocyte biology.

[19]  J. Jansson,et al.  Molecular analysis of the gut microbiota of identical twins with Crohn's disease , 2008, The ISME Journal.

[20]  M. Collins,et al.  Quantity and Distribution of Eosinophils in the Gastrointestinal Tract of Children , 2006, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[21]  John B Carlin,et al.  Regression models for twin studies: a critical review. , 2005, International journal of epidemiology.

[22]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[23]  O. Winqvist,et al.  Eosinophil granulocytes are activated during the remission phase of ulcerative colitis , 2005, Gut.

[24]  A. Duhamel,et al.  Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease , 2005, Gut.

[25]  T. Bouchard,et al.  Genetic and environmental influences on human psychological differences. , 2003, Journal of neurobiology.

[26]  P. Lichtenstein,et al.  The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies , 2002, Journal of internal medicine.

[27]  Y. Raab,et al.  A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease , 2002, American Journal of Gastroenterology.

[28]  A. Öst,et al.  A reproducible grading scale for histological assessment of inflammation in ulcerative colitis , 2000, Gut.

[29]  P. Venge,et al.  Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion , 1999, American Journal of Gastroenterology.

[30]  D G Altman,et al.  Statistics Notes: The use of transformation when comparing two means , 1996, BMJ.

[31]  M. Manns,et al.  Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease , 1996, Histopathology.

[32]  Walter W. Piegorsch,et al.  Design and analysis of reliability studies: The statistical evaluation of measurement errors. Graham Dunn, Oxford University Press, New York, 1989. No. of pages: ix + 198. Price: £25 , 1991 .

[33]  Graham Dunn,et al.  Design and Analysis of Reliability Studies: The Statistical Evaluation of Measurement Errors , 1989 .